Not a chance right now is someone going to give us what we're worth! We aren't selling cheap either! BOD knows what we have and isn't going to give away future earnings unless the BO is above $3 billion right now! Buyout is still 6-12 months away! Easy for me to watch and wait! Too many top cancer doc's think our platform has so many great things going that they are probably buying shares as well! I really don't thinks shorts are covering at all. I do think we have many people seeing our trial results 1st hand and are buying in. These oncologist have money and when they see our potential they get a little excited! We're as ways off from any slower deal yet. In the future you will see someone step up and offer a ridiculous amount to tie up the whole company! My honest guess would be AMGEN. They are flush with cash and realize that our platform holds the keys to make them a front runner pretty quick in the Immunotherapy space for Big Pharma's . Read about Amgen and you will realize they would be insane not to acquire us in the next year! To make sure I really believe Amgen is waiting on us to secure some kinda of EMA or FDA approval. So when the do buy us out for a ridiculous amount of money everyone in the Industry won't say what the Fluck? I really do believe they will be our ultimate acquirer! We will see. Amgen isn't stupid they know exactly what we have and if what we have is the next stepping stone in Immunotherapy they won't wait and be wishy washy they will make a tender offer and be done! Amgen came out of nowhere on our Pre-Clinical NEO Platform! They spent some money acquiring our NEO and I see them taking us out over time!
News 
Market Data 
Discover 
AI
